This study is currently not accepting new patients, but might later
Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes
Summary
- Eligibility
- for people ages 8 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Keywords
Eligibility
Locations
Details
- Status
- currently not accepting new patients, but might later
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Links
- Related Info
- ID
- NCT03929601
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 36 study participants
- Last Updated